MedMira Inc
- LAST PRICE0.1250
- TODAY'S CHANGE (%)-0.0050 (-3.8462%)
- Bid / Lots0.1200/ 20
- Ask / Lots0.1250/ 40
- Open / Previous Close0.1250 / 0.1300
- Day Range
- 52 Week Range
- Volume10,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIR |
|---|---|---|
| 11:00 ET | 5000 | 0.125 |
| 11:13 ET | 5000 | 0.125 |
Mar 14, 2023
Update on MedMira's Reveal TP (Syphilis) Clinical Trials in Canada, from 4:32PM ET on Tuesday Mar 14, 2023 by Accesswire
4:32PM ET on Tuesday Mar 14, 2023 by Accesswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MedMira Inc | 90.8M | -43.6x | --- |
Perimeter Medical Imaging AI Inc | 101.5M | -6.2x | --- |
Theralase Technologies Inc | 56.1M | -10.0x | --- |
Cannabix Technologies Inc | 47.4M | -12.8x | --- |
VentriPoint Diagnostics Ltd | 31.3M | -6.5x | --- |
Scryb Inc | 27.5M | -1.7x | --- |
Company Information
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care and in vitro sectors. Its products include Reveal HIV, Reveal G4, Reveal Rapid HIV Antibody Test, VYRACOVID-19, VYRACoV2Flu, REVEALCOVID-19 PLUS, REVEALCOVID-19 NabY Anti-RBD Antibody Test, Reveal TP rapid TP antibody test, Multiplo rapid TP/HIV test, Multiplo rapid HBc/HIV/HCV antibody test, Miriad HBc/HIV/HCV, Miriad HCV/HIV, Miriad TP/HIV/HCV, Miriad TP/HIV, Rapid Testing Reinvented Toolkit and other. Its subsidiaries include MedMira Inc., MedMira Laboratories Inc., Maple Biosciences Inc., MedMira International AG, MedMira (US) Inc. and Precious Life Savings Products.
Contact Information
- Headquarters
- 155 Chain Lake Dr.,, Suite 1HALIFAX, NS, Canada B3S 1B3
- Phone
- 902-450-1588
- Fax
- 902-450-1580
Executives
- Independent Chairman of the Board
- Thomas Bergmann
- Chief Executive Officer, Director
- Hermes Chan
- Chief Financial Officer
- Markus Meile
- Independent Director
- Steven Cummings
- Independent Director
- Jianhe Mao
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $90.8M |
|---|---|
Revenue (TTM) | $870.8K |
Shares Outstanding | 700.8M |
MedMira Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $-0.02 |
P/E Ratio | -43.6x |
Price/Sales (TTM) | 104.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -165.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
